Skip to main content
. Author manuscript; available in PMC: 2019 Feb 4.
Published in final edited form as: Vaccine. 2015 Jun 10;33(31):3709–3716. doi: 10.1016/j.vaccine.2015.05.091

Fig. 2.

Fig. 2.

Dual-correlate model surface plot mapping of predicted probability of survival at month 42 in the Human 4-IM Study Group. The surface grid illustrates the relationship among peak ED50, last anti-PA IgG response and survival probability calculated from the NHP survival data. Key: (|) mapping of peak ED50 and last anti-PA IgG response of individual humans from the 4-IM study group measured at month 42; (–) mapping of immune response to predicted survival probability from the surface grid; (→) mean predicted survival probability for the human 4-IM cohort at month 42.